Amundi Asset Management US’s Prothena Corp PRTA Stock Holding History

Amundi Asset Management US’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,800	Closed	-$76K	–	1652
2018 Q3	$76K	Buy	+5,800	New	+$83.8K	﹤0.01%	1542
2017 Q4	–	Sell	-57,962	Closed	-$3.75M	–	1568
2017 Q3	$3.75M	Sell	57,962 -82	-0.1%	-$5.02K	0.01%	407
2017 Q2	$3.14M	Sell	58,044 -57,888	-50%	-$3.08M	0.01%	434
2017 Q1	$6.47M	Sell	115,932 -492	-0.4%	-$25.8K	0.02%	379
2016 Q4	$5.73M	Sell	116,424 -2,900	-2%	-$160K	0.02%	382
2016 Q3	$7.16M	Sell	119,324 -634	-0.5%	-$34K	0.03%	367
2016 Q2	$4.19M	Buy	+119,958	New	+$5.22M	0.02%	433

Other funds holding PRTA

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Amundi Asset Management US's PRTA Position: Q4 2018 in Review

Amundi Asset Management US sold out of Prothena Corp (PRTA) in Q4 2018, closing a stake of 5,800 shares — an estimated $76K sold.

Amundi Asset Management US first reported a position in PRTA in Q2 2016 and held it in 7 quarters. The position peaked at $7.16M in Q3 2016. 120 funds tracked by Wall St. Rank hold PRTA as of Q4 2018.

Amundi Asset Management US reported no remaining Prothena Corp position as of Q4 2018 after selling out during the quarter.
Amundi Asset Management US sold 5,800 Prothena Corp shares in Q4 2018, an estimated $76K.
Amundi Asset Management US first reported a position in Prothena Corp in Q2 2016 and held it in 7 quarters.
Amundi Asset Management US's Prothena Corp position peaked at $7.16M in Q3 2016.
120 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2018.

Based on Amundi Asset Management US's 13F filing for Q4 2018, filed 14 Feb 2019.